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Introduction
Measles remains a significant cause of
childhood morbidity and mortality. Hall-
mark of the disease is a generalized
immune suppression that can last for
several weeks to months after resolution
of measles virus (MV) infection [1–3],
resulting in increased susceptibility to
opportunistic infections [4–7]. At the same
time, measles is associated with immune
activation and induces strong MV-specific
immune responses that confer lifelong
immunity [8]. This contradiction is known
as the ‘‘measles paradox’. Although mea-
sles-associated immune suppression has
been a subject of study since the beginning
of the 20th century [9], the importance of
possible underlying mechanisms remains
disputed.
The Immune System as ‘‘Viral
Friend’’
From the perspective of MV, cells of the
immune system are both friend and foe.
MV efficiently replicates in cells of the
immune system, especially during the
initial stages of the infection [10,11].
However, the virus preferentially infects
specific subsets of lymphocytes and den-
dritic cells (DCs). The relative susceptibil-
ity of these cells to MV infection is
governed by their expression level of the
cellular receptor CD150 [11–14]. Memo-
ry T-lymphocytes, which express CD150,
are preferentially infected [13,14]. In
secondary and tertiary lymphoid tissues,
the virus also replicates to high levels in
follicular and marginal zone B-lympho-
cytes [10,11,13]. DCs can also be infected
by MV [11,15–17] and may serve as initial
target cells [18,19].
The Immune System as ‘‘Viral
Foe’’
In the majority of cases MV infection is
self-limiting and induces strong virus-spe-
cific cellular and humoral immune respons-
es resulting in lifelong immunity [20]. Virus
neutralizing antibodies are an important
correlate of protection against MV infec-
tion, but cytotoxic T-lymphocytes are
crucial for clearance of infected cells [21–
23]. Resolution of MV infection is associ-
ated with increased lymphoproliferation
[8,24] and enlargement of lymph nodes
[13]. Thus, the immune system efficiently




Measles is associated with lymphopenia
[25] and extensive depletion of lympho-
cytes from lymphoid tissues [13,26,27].
However, lymphocyte numbers return to
normal within a week after clinical symp-
toms of measles have disappeared, while
measles immune suppression extends for
several weeks to months. Therefore, im-
mune cell depletion was initially dismissed
as a mechanism for measles immune
suppression [3]. Alternative mechanisms
have been proposed to explain measles-
associated immune suppression, as sum-
marized in Table 1. However, the rele-
vance of these observations to enhanced





Reduced responsiveness of peripheral
blood mononuclear cells to stimulation
with mitogens in vitro has been considered
an important mechanism underlying
measles-associated immune suppression.
Although the observations in these studies
are not disputed, we find it difficult to
reconcile this in vitro observation with the
observed immune activation in vivo.
Measles results in dramatic expansion of
MV-specific lymphocytes followed by res-
olution of viremia and lymphopenia
[8,25,28]. We recently demonstrated ex-
tensive lymphoproliferation in lymphoid
tissues early after MV infection in vivo
[13]. Thus, there is no evidence of
suppressed lymphoproliferative responses,
at least towards MV, in vivo. Rather, we
believe that alterations in the composition
of the peripheral lymphocyte populations
before and after measles may explain these
in vitro observations [13].
Do Dendritic Dells Play a Crucial
Role?
DC subsets have been shown suscepti-
ble to MV infection in vitro [15–17] and
in nonhuman primates in vivo [11,19].
Therefore, it is likely that infection,
depletion, or functional modulation of
DCs contributes to measles-associated
immune suppression. Nevertheless, anti-
gen presentation does not seem to be
impaired in vivo, as strong MV-specific
immune responses develop during the
acute stage of the disease.
Measles Damages the
Respiratory Epithelium
Whereas MV targets CD150 to infect
lymphoid and myeloid cells, the virus uses
poliovirus receptor like 4 (also known as
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nectin-4) as an alternative cellular receptor
to infect epithelial cells [29–31]. Whilst
infection of epithelial cells contributes to
viral transmission [32], MV also causes
extensive epithelial damage in the respira-
tory tract [33,34]. This epithelial injury
may provide an opportunity for respirato-
ry bacteria to adhere, replicate, and
invade with increased efficiency [35].
Table 1. Reported mechanisms of measles immune suppression.
Functional Impairment
Mechanism References
Suppression of lymphocyte proliferation [41–45]
Altered cytokine profiles [42,43,46–50]
Lymphoproliferation defect due to MV-infected DC [15,17,51]
Immune modulation mediated by viral proteins [44,52–56]
Modulation of cell membrane components [57,58]
Inhibition of hematopoiesis [59,60]
Depletion
Mechanism References
Lymphocyte infection & depletion [11,13,14,46,61–64]
Bystander lymphocyte apoptosis [65–67]
DC infection & depletion [11,16,68,69]
T-cell apoptosis after interaction with MV-infected DC [16,70]
doi:10.1371/journal.ppat.1004482.t001
Fig. 1. Schematic representation of the measles paradox. Different levels of lymphopenia (A), systemic virus loads (B), and virus-specific
immune responses (C) after subclinical (blue), mild (green), moderate (black), or severe (red) morbillivirus infections. Panel D shows a model for
immune suppression caused by moderate morbillivirus infection as shown in panels A, B, and C (adapted from [13]).
doi:10.1371/journal.ppat.1004482.g001
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Attenuated, Mild, Moderate, or
Severe Morbillivirus Infections
MV infections display a large variability
in clinical severity, ranging from vaccina-
tion with attenuated viruses, via subclinical
or mild infections, to severe disease. Closely
related animal morbilliviruses may even
overwhelm the immune system, resulting in
functional paralysis and virtual absence of
virus-specific immune responses [36–40].
This variation is also reflected in a wide
range of levels of lymphopenia, viremia,
and specific immune responses (Fig. 1A–C)
[13]. Natural MV infection of the naive
host will normally follow the pattern of
either a mild or moderate infection as
displayed in Fig. 1. Whereas mild measles
results in limited depletion of pre-existing
CD150+ memory lymphocytes, moderate
measles is associated with infection and
subsequent depletion of a large fraction of
those lymphocytes (Fig. 1D). Whether this
depletion is mediated by necrosis, apopto-
sis, pyroptosis, or cytotoxic T-cells remains
to be determined, but the effect is always
the same: to a varying degree, measles
erases immunological memory.
Future Directions: Studies in
Naturally Infected Measles
Patients
To improve our understanding of mea-
sles immune suppression, a transition from
in vitro to in vivo studies is required. Two
aspects are of crucial importance: viral
tropism and depletion of immune cell
subsets. We feel that it is important to
characterize the phenotype of MV-infected
cells during the prodromal phase of natural
measles, with special emphasis on infection
of DCs and memory lymphocytes. Further-
more, to address depletion of immune cell
subsets, paired blood samples from children
before and after measles will be required.
Staining of immune cells specific for
previously encountered pathogens, rather
than functional assays, will allow us to
distinguish between subset depletion and
functional paralysis.
Conclusions
Experimental MV infections in animal
models have demonstrated that percent-
ages of infected lymphocyte subsets are
higher than previously thought, especially
in secondary and tertiary lymphoid tissues
[11,13]. We believe that measles immune
suppression mainly results from depletion
of immune cell subsets, which is masked by
the rapid proliferation of MV-specific and
bystander lymphocytes (Fig. 1D). This
model is fully compatible with the measles
paradox. Clinical studies are required to
test our hypothesis that measles immune
suppression is mainly a numbers game.
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